Kvarnhammar, Anne Månsson
Veitonmäki, Niina
Hägerbrand, Karin
Dahlman, Anna
Smith, Karin Enell
Fritzell, Sara
von Schantz, Laura
Thagesson, Mia
Werchau, Doreen
Smedenfors, Kristine
Johansson, Maria
Rosén, Anna
Åberg, Ida
Winnerstam, Magnus
Nyblom, Eva
Barchan, Karin
Furebring, Christina
Norlén, Per
Ellmark, Peter
Article History
Received: 27 December 2018
Accepted: 19 March 2019
First Online: 11 April 2019
Ethics approval and consent to participate
: This study was approved by the Ethics Committee in Malmö/Lund, Sweden (approval number M142–15) and was conducted in accordance with International ethics guidelines, including the Declaration of Helsinki.
: Not applicable.
: The authors have been or are employees of Alligator Bioscience AB and have stocks and/or stock options in Alligator Bioscience AB. The authors do not have any financial competing interests. All the company-employed authors declare that their employment does not alter their adherence to the policies of Journal for Immunotherapy of Cancer.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.